I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
This is a prospective single arm, multi-center, phase II clinical trial to observe the efficacy and safety of VR-CAP (Velcade and Rituximab-Cyclophosphamide, Epirubicin and Prednisone) in the first-line treatment for patients with marginal zone lymphoma.
rituximab
lymphoma
bortezomib
prednisone
marginal zone lymphoma
- 0 views
- 19 Feb, 2024